Why are Women With Polycystic Ovary Syndrome at Increased Risk of Depression? Exploring the Etiological Maze

被引:12
|
作者
Gnawali, Anupa [1 ]
Patel, Viral [2 ]
Cuello-Ramirez, Alejandrina [3 ]
Al Kaabi, Anoud S. [4 ]
Noor, Asfa [2 ]
Rashid, Mohammed Y. [5 ]
Henin, Shereen [6 ]
Mostafa, Jihan A. [7 ]
机构
[1] Calif Inst Behav Neurosci & Psychol, Family Med, Fairfield, CA 94534 USA
[2] Calif Inst Behav Neurosci & Psychol, Res, Fairfield, CA USA
[3] Calif Inst Behav Neurosci & Psychol, Internal Med, Fairfield, CA USA
[4] Calif Inst Behav Neurosci & Psychol, Neonatol, Fairfield, CA USA
[5] Calif Inst Behav Neurosci & Psychol, Gen Surg, Fairfield, CA USA
[6] Calif Inst Behav Neurosci & Psychol, Internal Med, Pediat, Fairfield, CA USA
[7] Calif Inst Behav Neurosci & Psychol, Psychiat, Fairfield, CA USA
关键词
insulin resistance; hyperandrogenism; menstrual irregularities; polycystic ovary syndrome (pcos); depression; QUALITY-OF-LIFE; INSULIN-RESISTANCE; OBESITY; INFERTILITY; PARAMETERS; SYMPTOMS; ANXIETY; ASSOCIATIONS; PREVALENCE; EXPERIENCE;
D O I
10.7759/cureus.13489
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is a complex and common multisystemic disorder. Women with PCOS have up to eight times higher prevalence of depression than control groups. This paper aims to explore the underlying risk factors for developing depression in this high-risk group. Studies indicate an interplay of multiple mechanisms that place women with PCOS at an increased risk for depression. The pathophysiology thought to play a role includes disturbances in the endocrine axes and changes to the metabolic pathway. The risk of depression is independently linked to insulin resistance and obesity in this population. However, rates of depression were still higher than control groups when accounting for these variables, demonstrating that they are not the only mechanism causing depression. The clinical manifestations of hyperandrogenism and menstrual abnormalities may compound negative views and lower self-esteem and negatively impact mood. Many of these women also struggle with infertility, and due to the added external pressures like societal beliefs and culture, they may be further negatively impacted and worsen their depressive symptoms. The prevalence of depression in women with PCOS is high; thus, this paper highlights the essential understanding of the underlying mechanisms at play. This is to better aid in addressing the fundamental cause of depression in this high-risk group effectively.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Serum β-Klotho concentrations are increased in women with polycystic ovary syndrome
    Bednarska, Sylwia
    Fryczak, Jolanta
    Siejka, Agnieszka
    CYTOKINE, 2020, 134
  • [42] Increased serum neopterin levels in women with polycystic ovary syndrome
    Barutcuoglu, Burcu
    Bozdemir, A. Erkin
    Dereli, Didem
    Parildar, Zuhal
    Mutaf, M. Isil
    Ozmen, Dilek
    Bayindir, Oya
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2006, 36 (03): : 267 - 272
  • [43] Increased plasma visfatin concentrations in women with polycystic ovary syndrome
    Chan, Te-Fu
    Chen, Yi-Ling
    Chen, Hung-Hseng
    Lee, Chien-Hung
    Jong, Shiang-Bin
    Tsai, Eing-Mei
    FERTILITY AND STERILITY, 2007, 88 (02) : 401 - 405
  • [44] Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?
    Carmina, Enrico
    Lobo, Roger A.
    JOURNAL OF WOMENS HEALTH, 2018, 27 (11) : 1385 - 1388
  • [45] WOMEN WITH POLYCYSTIC OVARY SYNDROME AND RISK OF CARDIOVASCULAR DISEASE
    Blagojevic, Iva Perovic
    Eror, Tatjana
    Pelivanovic, Jovana
    Jelic, Svetlana
    Kotur-Stevuljevic, Jelena
    Ignjatovic, Svetlana
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2017, 36 (03) : 259 - 269
  • [46] Cardiovascular disease risk in women with polycystic ovary syndrome
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 (1): : 7 - 7
  • [47] Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
    Paterakis, Thomas S.
    Diamanti-Kandarakis, Evanthia
    CURRENT OBESITY REPORTS, 2014, 3 (04): : 377 - 386
  • [48] Carcinoma risk in women with polycystic ovary syndrome (PCOS)
    Weiss, JM
    Ortmann, O
    GYNAKOLOGE, 2002, 35 (01): : 31 - 35
  • [49] Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome
    Armeni, Eleni
    Lambrinoudaki, Irene
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (06) : 579 - 590
  • [50] Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
    Thomas S. Paterakis
    Evanthia Diamanti-Kandarakis
    Current Obesity Reports, 2014, 3 (4) : 377 - 386